- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07591766
Aerobic Dance Exercises in Fibromyalgia Syndrome
15 mai 2026 mis à jour par: Tugba Civi Karaaslan, Istanbul University
The Effectiveness of Aerobic Dance Exercises in Fibromyalgia Syndrome: A Randomized Controlled Trial
The aim of this study was to evaluate the effects of aerobic dance exercises on patients with Fibromyalgia syndrome (FMS) and to compare these effects with those of conventional postural exercises.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
The aim of this study was to evaluate the effects of aerobic dance exercises on patients with Fibromyalgia syndrome (FMS) and to compare these effects with those of conventional postural exercises.
A total of 44 female participants were included.
Group-1 (n=22) received aerobic dance exercises twice a week for eight weeks, while Group-2 (n=22) was given a conventional postural exercise program as a home-based intervention with the same duration and frequency.
To evaluate the participants, the following assessment tools were used: Fibromyalgia Impact Questionnaire, McGill-Melzack Pain Questionnaire, Short Form-36, Pittsburgh Sleep Quality Index, Beck Depression Inventory, International Physical Activity Questionnaire-Short Form, and Fatigue Severity Scale.
Both groups showed significant improvements in nearly all parameters after the intervention (p<0.05).
Type d'étude
Interventionnel
Inscription (Réel)
44
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- Istanbul University-Cerrahpaşa
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- diagnosis of FMS according to the American College of Rheumatology (ACR) diagnostic criteria
- being female between the ages of 18 and 65
- having the physical capacity to exercise
Exclusion Criteria:
- unstable angina pectoris with severe dyspnea that would prevent exercise
- the presence of any neurological or orthopedic disease other than FMS
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Aerobic Dance Exercises
The aerobic protocol for Group-1 was divided into four distinct phases: warm-up, endurance training, stretching, and cooling down.
These sessions were led by a physiotherapist in groups of five, using music to guide the exercise rhythm.
Initial warm-ups lasted 5 to 7 minutes and involved stationary marching and stepping patterns.
A 20-minute core segment followed, featuring group dance movements that incorporated various torso and limb rotations.
Cardiovascular challenge was integrated through 5 minutes of rapid-paced dance.
The program ended with a 5-minute cool-down period where participants gradually reduced their activity level in alignment with a slowing musical tempo.
|
The aerobic protocol for Group-1 was divided into four distinct phases: warm-up, endurance training, stretching, and cooling down.
These sessions were led by a physiotherapist in groups of five, using music to guide the exercise rhythm.
Initial warm-ups lasted 5 to 7 minutes and involved stationary marching and stepping patterns.
A 20-minute core segment followed, featuring group dance movements that incorporated various torso and limb rotations.
Cardiovascular challenge was integrated through 5 minutes of rapid-paced dance.
The program ended with a 5-minute cool-down period where participants gradually reduced their activity level in alignment with a slowing musical tempo.
|
|
Expérimental: Conventional Exercises
To improve muscle balance and protect spinal integrity, Group-2 performed conventional posture exercises targeting the neck, back, core, and shoulders.
This routine, a common clinical approach for individuals with FMS, was conducted as a home-based program with a frequency of two sessions per week.
To ensure compliance and track progress, each participant utilized a dedicated exercise diary to record their activities throughout the study.
|
To improve muscle balance and protect spinal integrity, Group-2 performed conventional posture exercises targeting the neck, back, core, and shoulders.
This routine, a common clinical approach for individuals with FMS, was conducted as a home-based program with a frequency of two sessions per week.
To ensure compliance and track progress, each participant utilized a dedicated exercise diary to record their activities throughout the study.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Fibromyalgia Impact Scale
Délai: change from baseline at 8 weeks
|
To measure the impact of the disease on daily life, a 20-question assessment tool was utilized, focusing on domains such as physical capacity, occupational health, and psychological well-being.
Additionally, the scale screens for pain intensity, stiffness, sleep quality, and overall vitality.
The scoring system is structured such that higher results indicate more pronounced symptoms and lower functional capacity, while lower scores reflect better health status.
Total scores range from 0 to 100, with higher scores indicating greater disease impact and poorer functional status.
|
change from baseline at 8 weeks
|
|
McGill-Melzack Pain Scale
Délai: change from baseline at 8 weeks
|
To characterize the nature and intensity of the pain, the McGill-Melzack scale was utilized.
This assessment encompasses a detailed analysis of pain topography, its sensory qualities, and duration.
It also accounts for specific triggers or modifiers of pain frequency.
Scoring is interpreted such that higher cumulative values reflect more profound pain symptoms and increased clinical severity.Total scores range from 0 to 78, with higher scores indicating greater pain severity and pain-related distress
|
change from baseline at 8 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Short Form-36 Health Survey (SF-36)
Délai: change from baseline at 8 weeks
|
The Short Form-36 Health Survey is a comprehensive 36-item questionnaire used to assess health-related quality of life, including physical functioning, psychosocial functioning, pain, and mental health status.
Each subscale is scored on a scale ranging from 0 to 100, with higher scores indicating better functional status and improved overall health-related quality of life.
|
change from baseline at 8 weeks
|
|
Pittsburgh Sleep Quality Index
Délai: change from baseline at 8 weeks
|
The PSQI was utilized to measure participants' self-reported sleep quality and related disturbances.
The scale comprises 19 items that form seven sub-scores, which are then aggregated into a single global score between 0 and 21.
While lower scores are indicative of better sleep quality, a cumulative score higher than five is clinically interpreted as a sign of significant sleep dysfunction.
|
change from baseline at 8 weeks
|
|
Beck Depression Inventory
Délai: change from baseline at 8 weeks
|
To evaluate participants' depressive states, the BDI, which consists of 21 questions, was utilized.
Each item is scored between 0 and 3, and the total score is used to determine the intensity of the symptoms.
Clinical classifications were made based on the total score: 0-9 points as no depression, 10-16 points as mild, 17-23 points as moderate, and any value 24 or above as severe depression.
|
change from baseline at 8 weeks
|
|
International Physical Activity Questionnaire-Short Form
Délai: change from baseline at 8 weeks
|
The International Physical Activity Questionnaire-Short Form will be used to assess participants' physical activity levels.
The questionnaire evaluates the frequency and duration of walking, moderate-intensity activity, vigorous-intensity activity, and sedentary behavior over the last 7 days.
Total physical activity is calculated in metabolic equivalent (MET)-minutes/week.
Higher scores indicate higher levels of physical activity.
|
change from baseline at 8 weeks
|
|
Fatigue Severity Scale
Délai: change from baseline at 8 weeks
|
To evaluate the impact of fatigue, the FSS, which views fatigue severity as a single-dimensional construct, was administered.
Participants responded to nine statements using a scoring range from 1 to 7. The overall fatigue score was derived from the average of these ratings; consequently, an increase in the total score indicates a greater level of perceived fatigue.
|
change from baseline at 8 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
6 mai 2022
Achèvement primaire (Réel)
6 janvier 2023
Achèvement de l'étude (Réel)
6 mai 2023
Dates d'inscription aux études
Première soumission
5 mai 2026
Première soumission répondant aux critères de contrôle qualité
15 mai 2026
Première publication (Réel)
18 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
18 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
15 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IstanbulUC4
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .